ARS Pharmaceuticals, Inc. SPRY Quick ratio
Quick ratio at other companies
Other financials
Where this comes from
Calculated from ARS Pharmaceuticals, Inc.’s reported figures.
Based on the most recent quarter.
The official record: ARS Pharmaceuticals, Inc.’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about ARS Pharmaceuticals, Inc.'s quick ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ARS Pharmaceuticals, Inc.'s quick ratio?
- ARS Pharmaceuticals, Inc. (SPRY) reported quick ratio of 4.5× in Q1 2026.
- How has ARS Pharmaceuticals, Inc.'s quick ratio changed year-over-year?
- ARS Pharmaceuticals, Inc.'s quick ratio decreased by 57.7% year-over-year, from 10.6× to 4.5×.
- What is the long-term trend for ARS Pharmaceuticals, Inc.'s quick ratio?
- Over 5 years (2020 to 2025), ARS Pharmaceuticals, Inc.'s quick ratio has grown at a -30.3% compound annual growth rate (CAGR), from 40.7× to 6.7×.
- What does quick ratio mean?
- Current assets excluding inventory, divided by current liabilities at the quarter end (the 'acid-test'). A stricter liquidity measure that excludes the least-liquid current asset.